Duodenal Ulcer Treatment Market Report 2026

Duodenal Ulcer Treatment Market Overview

• Duodenal Ulcer Treatment market size has reached to $107.34 billion in 2025 • Expected to grow to $151.77 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: Increase In Cigarette Smokers Drives Growth Of Duodenal Ulcer Treatment Market • Market Trend: Akums Drugs Launches Innovative Combikit To Treat Duodenal Ulcers Associated with H. pylori • North America was the largest region in 2025.

What Is Covered Under Duodenal Ulcer Treatment Market?

Duodenal ulcer treatment refers to the therapeutic approaches to healing and managing ulcers in the duodenum, the first part of the small intestine. This treatment involves a combination of medications to reduce acid production and promote healing, lifestyle changes, and, in some cases, interventions to eradicate Helicobacter pylori bacteria, a common cause of duodenal ulcers. The main types of duodenal ulcer treatment are antibiotics, proton pump inhibitors, antacids, potassium-competitive acid blockers, h2-antagonists, ulcer protective drugs, and surgery. Antacids are medications used to treat bacterial infections, such as those caused by Helicobacter pylori, which can lead to duodenal ulcers. This helps in eliminating the bacterial infection and allowing the ulcer to heal properly. The various applications include adults and elderly. The various distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Duodenal Ulcer Treatment Market Growth Forecast?

The duodenal ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $151.77 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to antibiotic resistance management, novel acid blockers, early diagnosis programs, outpatient ulcer management, personalized gastroenterology care. Major trends in the forecast period include increasing use of combination drug therapy, rising focus on helicobacter pylori eradication, expansion of proton pump inhibitor usage, growth of minimally invasive surgical interventions, improved patient compliance through simplified regimens.

Global Duodenal Ulcer Treatment Market Segmentation

1) By Type: Antibiotics, Proton Pump Inhibitors, Antacids, Potassium-Competitive Acid Blockers, H2-Antagonist, Ulcer Protective Drugs, Surgery 2) By Application: Adult, Elderly 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments: 1) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline, Levofloxacin 2) By Proton Pump Inhibitors (PPIs): Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole 3) By Antacids: Magnesium Hydroxide, Aluminum Hydroxide, Calcium Carbonate, Sodium Bicarbonate 4) By Potassium-Competitive Acid Blockers (P-CABs): Vonoprazan, Tegoprazan 5) By H2-Antagonists (H2 Blockers): Ranitidine, Famotidine, Cimetidine, Nizatidine 6) By Ulcer Protective Drugs: Sucralfate, Misoprostol, Bismuth Subsalicylate 7) By Surgery: Partial Gastrectomy, Vagotomy, Pyloroplasty, Endoscopic Therapy

What Is The Driver Of The Duodenal Ulcer Treatment Market?

The increase in the number of cigarette smokers is expected to propel the growth of the duodenal ulcer treatment market going forward. A cigarette smoker is an individual who habitually consumes cigarettes containing tobacco, which is inhaled and exhaled through burning combustion. Cigarette smoking is increasing due to cultural influences, socioeconomic factors, stress-related behavior, and wider access to nicotine products. The duodenal ulcer treatment market supports this trend by providing ulcer-specific therapies, smoking-cessation support, lifestyle guidance, and continuous monitoring to enhance healing and reduce recurrence. For instance, in October 2024, according to the European Respiratory Society's (ERS), a Switzerland-based non-profit organization, a study covering smoking trends among young people revealed a significant rise in smoking rates, with 22.5% of respondents smoking in 2022 compared to 40.1% in 2024. Therefore, the increase in the number of cigarette smokers is driving the growth of the duodenal ulcer treatment industry.

Key Players In The Global Duodenal Ulcer Treatment Market

Major companies operating in the duodenal ulcer treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz AG, Sun Pharmaceutical Industries Limited, Eisai Co. Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Limited, Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Jubilant Pharma Limited, Torrent Pharmaceuticals Limited

Global Duodenal Ulcer Treatment Market Trends and Insights

Major companies operating in the duodenal ulcer treatment market are focusing on developing innovative products such as combikits for duodenal ulcers and Helicobacter pylori (H. pylori) infection to improve healing outcomes and enhance treatment effectiveness. A combikit for duodenal ulcer and H. pylori infection refers to a combination therapy pack containing multiple medications designed to work together to eradicate H. pylori bacteria while reducing gastric acid production, thereby addressing both the cause and symptoms of duodenal ulcers. For instance, in April 2023, Akums Drugs and Pharmaceutical Limited, an India-based pharmaceutical company, launched an innovative Combikit for treating duodenal ulcers associated with H. pylori infection. The kit includes amoxicillin, clarithromycin, and esomeprazole, a combination that inhibits bacterial growth and reduces gastric acid secretion. Approved by the Central Drugs Standard Control Organization (CDSCO), this Combikit offers an effective, integrated approach for treating duodenal ulcers and eradicating H. pylori in patients with active or healed peptic ulcers.

What Are Latest Mergers And Acquisitions In The Duodenal Ulcer Treatment Market?

In July 2024, Zydus Lifesciences Limited, an India-based pharmaceutical company, partnered with Takeda Pharmaceutical Company to secure a non-exclusive patent licensing agreement for marketing Vonoprazan (Vault®) in India. This partnership aims to expand Zydus’s gastroenterology portfolio by introducing a next-generation acid-suppressing therapy in India and to improve patient access to innovative treatments for acid-related disorders. Takeda Pharmaceutical Company, a Japan-based company that provides treatments for duodenal ulcers.

Regional Outlook

North America was the largest region in the duodenal ulcer treatment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Duodenal Ulcer Treatment Market?

The duodenal ulcer treatment market consists of revenues earned by entities by providing services such as endoscopic therapies, follow-up care, and lifestyle and dietary changes. The market value includes the value of related goods sold by the service provider or included within the service offering. The duodenal ulcer treatment market also includes sales of endoscopic devices, surgical instruments, H2-receptor antagonists, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Duodenal Ulcer Treatment Market Report 2026?

The duodenal ulcer treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the duodenal ulcer treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.